EcoR1 Venture Opportunity Fund Overview
EcoR1 Venture Opportunity Fund General Information
Description
EcoR1 Venture Opportunity Fund is a venture capital fund managed by EcoR1 Capital. The fund is located in San Francisco, California. The fund targets to invest in the biotechnology and life sciences sectors.
Contact Information
Fund Manager's Location
- 357 Tehama Street
- Floor 3
- San Francisco, CA 94103
- United States
EcoR1 Venture Opportunity Fund Investments (10)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Actio Biosciences | 28-Jul-2022 | Drug Discovery | Generating Revenue | |||
| Affinia Therapeutics | 03-May-2021 | Drug Discovery | Pre-Clinical Trials | |||
| Janux Therapeutics | 20-Apr-2021 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Aktis Oncology | 18-Mar-2021 | Drug Discovery | Pre-Clinical Trials | |||
| Shattuck Labs | 12-Jun-2020 | Biotechnology | Clinical Trials - Phase 1 | |||
| Amagma Therapeutics | 27-Feb-2020 | Drug Discovery | Pre-Clinical Trials | |||
| Avidity Biosciences | 13-Nov-2019 | Drug Discovery | Generating Revenue | |||
| Kumquat Biosciences | 08-Sep-2019 | Drug Discovery | Startup | |||
| Avidity Biosciences | 05-Jan-2017 | Early Stage VC (Series B) | Drug Discovery | Startup | ||
| Aldila Therapeutics | Early Stage VC | Other Commercial Products | Stealth |
EcoR1 Venture Opportunity Fund Investment Strategy
Investments by Industry
Investments by Deal Type
EcoR1 Venture Opportunity Fund Team (3)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Oleg Nodelman | Founder & Non-Executive Member of the board | San Francisco, CA | |||
| Caroline Stout | Partner | San Francisco, CA | |||
| Scott Platshon | Partner | San Francisco, CA |
EcoR1 Venture Opportunity Fund Returns Data
The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.
IRR (%)
DPI (x)
RVPI (x)
TVPI (x)
EcoR1 Venture Opportunity Fund Benchmark (695)
| Fund Name | Fund Type | Vintage | IRR | Quartile | As of Date |
|---|---|---|---|---|---|
| TIFIN Capital Partners Fund | |||||
| Developer Integration Fund | |||||
| Vestigo Ventures Fund II | |||||
| SpaceFund One | |||||
| American Family Ventures Fund III | |||||
| Curative Ventures V | |||||
| IV Lonestar | 31-Mar-2022 | ||||
| Patamar Fund II | |||||
| LRI Vision Partners Fund II | |||||
| R3 Development Fund |
EcoR1 Venture Opportunity Fund FAQs
-
What is EcoR1 Venture Opportunity Fund?
EcoR1 Venture Opportunity Fund is a venture capital fund managed by EcoR1 Capital.
-
Who manages EcoR1 Venture Opportunity Fund?
EcoR1 Venture Opportunity Fund is managed by EcoR1 Capital.
-
Where is EcoR1 Venture Opportunity Fund domiciled?
EcoR1 Venture Opportunity Fund is domiciled in United States: Delaware and Cayman Islands.
-
What is EcoR1 Venture Opportunity Fund's size?
EcoR1 Venture Opportunity Fund has a size of .
-
What type of fund is EcoR1 Venture Opportunity Fund?
The fund type of EcoR1 Venture Opportunity Fund is Venture.
-
What is the status of EcoR1 Venture Opportunity Fund?
EcoR1 Venture Opportunity Fund is closed.
-
What has EcoR1 Venture Opportunity Fund invested in?
EcoR1 Venture Opportunity Fund has made numerous investments in companies like Actio Biosciences, Affinia Therapeutics, and Janux Therapeutics within the Drug Discovery industry.
-
What has EcoR1 Venture Opportunity Fund invested in recently?
EcoR1 Venture Opportunity Fund's latest investment was on 28-Jul-2022 in Actio Biosciences, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
